Estrogen and Progesterone Receptor Expression in Postmenopausal Tamoxifen-Exposed Endometrial Pathologies

By Cohen I.   Beyth Y.   Altaras M.M.   Shapira J.   Tepper R.   Cardoba M.   Yigael D.   Figer A.   Fishman A.   Berenhein J.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 8-15

Elsevier

Access to resources Recommend Favorite

Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis

By Vrieling Alina   Buck Katharina   Kaaks Rudolf   Chang-Claude Jenny  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 641-649

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen sensitivity of normal human breast tissue in vivo and implanted into athymic nude mice: Analysis of the relationship between estrogen-induced proliferation and progesterone receptor expression

By Clarke R.B.  

Breast Cancer Research and Treatment, Vol. 45, Iss. 2, 1997-09 ,pp. : 121-133

Springer Publishing Company

Access to resources Recommend Favorite

Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer

By Hosoda Mitsuchika   Yamamoto Mitsugu   Nakano Kiichiroh   Hatanaka Kanako   Takakuwa Emi   Hatanaka Yutaka   Matsuno Yoshihiro   Yamashita Hiroko  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 249-261

Springer Publishing Company

Access to resources Recommend Favorite

Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells

By            

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2689-2694

Spandidos Publications

Access to resources Recommend Favorite